Hemogenyx Share News (HEMO)
HEMO Share
HEMO Share
HEMO Share
HEMO Share
HEMO
HEMO Share
HEMO Level 2
HEMO Live
HEMO Broker
HEMO Directors
HEMO Financial
HEMO
HEMO Short
HEMO
Last checked at -
Mon, 26th Apr 2021 09:51
Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Receives convertible loan note conversion notice from Mint Capital Advisors Ltd. Notice is in respect to GBP900,000 worth of notes issued on February 3. Hemogenyx to issue 29.9 million shares at conversion price of GBP0.03015 each.
Current stock price: 2.94 pence, down 16% on Monday
Year-to-date change: down 70%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
SMALL-CAP WINNERS & LOSERS: TBC Bank swings to first quarter profit
Read moreTRADING UPDATES: Asimilar and Worldsec swing to profit
Read moreSMALL-CAP WINNERS & LOSERS: Petrofac gets boost from SocGen upgrade
Read moreIN BRIEF: Hemogenyx starts talks with GlobalCo over CDX licensing
Read moreTRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe
Read moreTRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles
Read moreTRADING UPDATES: Yellow Cake And Asiamet Resources Plan Fundraises
Read moreIN BRIEF: Hemogenyx Draws Down GBP12 Million From Financing Facility
Read moreIN BRIEF: Hemogenyx Completes Development Of CDX Antibody
Read moreIN BRIEF: Hemogenyx Pharmaceuticals Teams With Pennsylvania University
Read moreIN BRIEF: Hemogenyx Nets Financing Facility Of Up To GBP60 Million
Read moreIN BRIEF: Hemogenyx Extends Antibody Development Pact Due To Virus
Read moreUK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise
Read moreUK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula
Read more
Last checked at